International Flavors (IFF) reported $2.76 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 4.3%. EPS of $1.15 for the same period compares to $1.16 a year ago.
The reported revenue represents a surprise of +1.19% over the Zacks Consensus Estimate of $2.73 billion. With the consensus EPS estimate being $1.11, the EPS surprise was +3.6%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how International Flavors performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Sales- Health & Biosciences: $577 million versus the four-analyst average estimate of $571.71 million. The reported number represents a year-over-year change of +3.4%.
- Net Sales- Food Ingredients: $850 million versus the four-analyst average estimate of $834.65 million.
- Net sales- Scent: $603 million versus $608.69 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a 0% change.
- Net sales- Taste: $631 million compared to the $633.74 million average estimate based on four analysts.
- Net Sales- Pharma Solutions: $103 million versus $120.11 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -58.8% change.
- Adjusted Operating EBITDA- Health & Biosciences: $151 million versus the four-analyst average estimate of $151.69 million.
- Adjusted Operating EBITDA- Scent: $130 million versus the four-analyst average estimate of $135.15 million.
- Adjusted Operating EBITDA- Food Ingredients: $124 million versus $111.08 million estimated by four analysts on average.
- Adjusted Operating EBITDA- Taste: $125 million versus $129.96 million estimated by four analysts on average.
- Adjusted Operating EBITDA- Pharma Solutions: $22 million compared to the $24.58 million average estimate based on three analysts.
View all Key Company Metrics for International Flavors here>>>
Shares of International Flavors have returned -6.5% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
International Flavors & Fragrances Inc. (IFF): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
